Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has been given an average rating of “Buy” by the ten analysts that are currently covering the firm, MarketBeat reports. Nine investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target […]
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) reached a new 52-week high during trading on Wednesday . The company traded as high as $40.63 and last traded at $40.05, with a volume of 295845 shares trading hands. The stock had previously closed at $39.66. Analyst Upgrades and Downgrades Several research analysts have issued reports […]
Revolution Medicines (NASDAQ:RVMD) Earns Buy Rating from Needham & Company LLC themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Revolution Medicines (NASDAQ:RVMD – Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.75) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link. Revolution […]
Brokerages Set Revolution Medicines, Inc (NASDAQ:RVMD) Target Price at $41 20 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.